National University Corporation Tokyo Medical and Dental University
发明人:
申请号：
EP12785073.3
公开号：
EP2711023A1
申请日:
2012.05.11
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
The purpose of the present invention is to provide an osteogenesis promoter for directly promoting osteogenesis by osteoblasts, and an agent for preventing and treating bone disease. The present invention is characterized in that a binding inhibitor substance of semaphorin 4D and plexin B1 is used. For the binding inhibitor substance, suitable examples include anti-semaphorin 4D antibody, anti-plexin B1 antibody, and protein comprising the extracellular domain of plexin B1
